IBDEI0YT ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16351,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,16352,0)
 ;;=I35.0^^64^740^11
 ;;^UTILITY(U,$J,358.3,16352,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16352,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis
 ;;^UTILITY(U,$J,358.3,16352,1,4,0)
 ;;=4^I35.0
 ;;^UTILITY(U,$J,358.3,16352,2)
 ;;=^5007174
 ;;^UTILITY(U,$J,358.3,16353,0)
 ;;=I35.1^^64^740^10
 ;;^UTILITY(U,$J,358.3,16353,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16353,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Insufficiency
 ;;^UTILITY(U,$J,358.3,16353,1,4,0)
 ;;=4^I35.1
 ;;^UTILITY(U,$J,358.3,16353,2)
 ;;=^5007175
 ;;^UTILITY(U,$J,358.3,16354,0)
 ;;=I35.2^^64^740^12
 ;;^UTILITY(U,$J,358.3,16354,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16354,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis w/ Insufficiency
 ;;^UTILITY(U,$J,358.3,16354,1,4,0)
 ;;=4^I35.2
 ;;^UTILITY(U,$J,358.3,16354,2)
 ;;=^5007176
 ;;^UTILITY(U,$J,358.3,16355,0)
 ;;=I35.9^^64^740^9
 ;;^UTILITY(U,$J,358.3,16355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16355,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,16355,1,4,0)
 ;;=4^I35.9
 ;;^UTILITY(U,$J,358.3,16355,2)
 ;;=^5007178
 ;;^UTILITY(U,$J,358.3,16356,0)
 ;;=I42.7^^64^740^3
 ;;^UTILITY(U,$J,358.3,16356,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16356,1,3,0)
 ;;=3^Cardiomyopathy d/t Drug/External Agent
 ;;^UTILITY(U,$J,358.3,16356,1,4,0)
 ;;=4^I42.7
 ;;^UTILITY(U,$J,358.3,16356,2)
 ;;=^5007198
 ;;^UTILITY(U,$J,358.3,16357,0)
 ;;=I21.3^^64^740^14
 ;;^UTILITY(U,$J,358.3,16357,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16357,1,3,0)
 ;;=3^STEMI,Unspec Site
 ;;^UTILITY(U,$J,358.3,16357,1,4,0)
 ;;=4^I21.3
 ;;^UTILITY(U,$J,358.3,16357,2)
 ;;=^5007087
 ;;^UTILITY(U,$J,358.3,16358,0)
 ;;=I25.5^^64^740^8
 ;;^UTILITY(U,$J,358.3,16358,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16358,1,3,0)
 ;;=3^Ischemic Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,16358,1,4,0)
 ;;=4^I25.5
 ;;^UTILITY(U,$J,358.3,16358,2)
 ;;=^5007115
 ;;^UTILITY(U,$J,358.3,16359,0)
 ;;=I25.9^^64^740^6
 ;;^UTILITY(U,$J,358.3,16359,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16359,1,3,0)
 ;;=3^Chronic Ischemic Heart Disease,Unspec
 ;;^UTILITY(U,$J,358.3,16359,1,4,0)
 ;;=4^I25.9
 ;;^UTILITY(U,$J,358.3,16359,2)
 ;;=^5007144
 ;;^UTILITY(U,$J,358.3,16360,0)
 ;;=I25.10^^64^740^2
 ;;^UTILITY(U,$J,358.3,16360,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16360,1,3,0)
 ;;=3^Athscl Hrt Dis Ntv Cor Art w/o Ang Pctrs
 ;;^UTILITY(U,$J,358.3,16360,1,4,0)
 ;;=4^I25.10
 ;;^UTILITY(U,$J,358.3,16360,2)
 ;;=^5007107
 ;;^UTILITY(U,$J,358.3,16361,0)
 ;;=D64.9^^64^740^1
 ;;^UTILITY(U,$J,358.3,16361,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16361,1,3,0)
 ;;=3^Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,16361,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,16361,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,16362,0)
 ;;=I42.9^^64^740^4
 ;;^UTILITY(U,$J,358.3,16362,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16362,1,3,0)
 ;;=3^Cardiomyopathy,Unspec
 ;;^UTILITY(U,$J,358.3,16362,1,4,0)
 ;;=4^I42.9
 ;;^UTILITY(U,$J,358.3,16362,2)
 ;;=^5007200
 ;;^UTILITY(U,$J,358.3,16363,0)
 ;;=I67.9^^64^740^5
 ;;^UTILITY(U,$J,358.3,16363,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16363,1,3,0)
 ;;=3^Cerebrovascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,16363,1,4,0)
 ;;=4^I67.9
 ;;^UTILITY(U,$J,358.3,16363,2)
 ;;=^5007389
 ;;^UTILITY(U,$J,358.3,16364,0)
 ;;=F04.^^64^741^2
 ;;^UTILITY(U,$J,358.3,16364,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16364,1,3,0)
 ;;=3^Amnestic Disorder d/t Physiological Condition
 ;;^UTILITY(U,$J,358.3,16364,1,4,0)
 ;;=4^F04.
 ;;^UTILITY(U,$J,358.3,16364,2)
 ;;=^5003051
